biblio
, “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
, “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
, “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
, “Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold”, Chemical Biology & Drug Design, vol. 85, no. 2, pp. 201-207, 2015.
, “Synthesis, structure and DNA interaction studies of bisphosphoramides: theoretical and experimental insights”, Inorganica Chimica Acta, vol. 461, pp. 84-91, 2017.
, “Synthesis of novel of 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study”, Bioorganic & Medicinal Chemistry Letters, vol. 30, no. 12, p. 127136, 2020.
, “Synthesis, biological valuation, and QSAR studies of novel pyrazole bearing pyridyl oxadiazole analogues as potential antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 712-727, 2016.
, “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
, “Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars”, Synthetic Communications, vol. 48, no. 5, pp. 524-540, 2018.
, “Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis”, Chemical Biology & Drug Design, vol. 90, no. 6, pp. 1206-1214, 2017.
, “Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents”, Research on Chemical Intermediates, vol. 42, no. 3, pp. 2707-2729, 2016.
, “Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.
, “Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.
, “Synthesis and biological evaluation of new fluconazole β-lactam conjugates linked via 1,2,3-triazole”, New Journal of Chemistry, vol. 41, no. 2, pp. 470-479, 2017.
, “Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.
, “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
, “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
, “Quinolidene-rhodanine conjugates: facile synthesis and biological evaluation”, European Journal of Medicinal Chemistry, vol. 125, pp. 385–399, 2017.
, “Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: synthesis and molecular docking study”, Bioorganic & medicinal chemistry letters, vol. 27, no. 4, pp. 922-928, 2017.
, “Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking”, Medchemcomm, vol. 7, no. 9, pp. 1832-1848, 2016.
, “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
, “New pimarane diterpenes and other antimycobacterial metabolites from anisochilus verticillatus”, Natural Product Research, vol. 30, no. 6, pp. 675-681, 2016.
, “New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 2, pp. 288–294, 2017.
, “New 1,2,3-triazole-appended bis-pyrazoles: synthesis, bioevaluation, and molecular docking”, ACS Omega, vol. 6, no. 38, pp. 24879-24890, 2021.
, “Molecular interaction of selected phytochemicals under the charged environment of Plasmodium falciparum chloroquine resistance transporter (PfCRT) model”, Journal of Biomolecular Structure & Dynamics, vol. 34, no. 2, pp. 290-303, 2016.
, “Isolates of alpinia officinarum hance as COX-2 inhibitors: evidence from anti-inflammatory, antioxidant and molecular docking studies”, International Immunopharmacology, vol. 33, pp. 8-17, 2016.
, “In vitro and ex vivo antitubercular activity of diarylheptanoids from the rhizomes of alpinia officinarum hance”, Natural Product Research, vol. 30, no. 24, pp. 2825-2830, 2016.
, “In silico studies, synthesis and antitubercular activity of some novel quinoline - azitidinone derivatives”, Current Computer-Aided Drug Design, vol. 17, no. 1, pp. 134-143, 2021.
, “Facile synthesis of new N-sulfonamidyl-4-thiazolidinone derivatives and their biological evaluation”, New Journal of Chemistry, vol. 40, no. 4, pp. 3047-3058, 2016.
, “Facile and solvent-free domino synthesis of new quinolidinyl-2,4-thiazolidinones: antifungal activityand molecular docking”, Mini-Reviews in Medicinal Chemistry, vol. 18, no. 7, pp. 622-630, 2018.
, “Evaluation of imidazolium-based ionic liquids towards vermicidal activity: in vitro & in silico studies”, RSC Advances, vol. 5, no. 92, pp. 75415-75424, 2015.
, “Design, synthesis, structural characterization by IR, 1H, 13C, 15N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors”, Chemical Biology & Drug Design, vol. 81, no. 6, pp. 715-729, 2013.
, “Design, synthesis of anticancer and anti-inflammatory 4-(1-methyl-1H-indol-3-yl)-6-(methylthio) pyrimidine-5-carbonitriles”, Synthetic Communications, vol. 52, no. 5, pp. 733-744, 2022.
, “Design, synthesis, and biological evaluation of novel fluorinated pyrazole encompassing pyridyl 1,3,4-oxadiazole motifs”, Medicinal Chemistry Research, vol. 25, no. 11, pp. 2698-2717, 2016.
, “Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents”, European Journal of Medicinal Chemistry, vol. 122, pp. 475-487, 2016.
, “Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents”, Bioorganic Chemistry, vol. 86, pp. 507-512, 2019.
, “Design and synthesis of 11 alpha-substituted bile acid derivatives as potential anti-tuberculosis agents”, Bioorganic & Medicinal Chemistry Letters, vol. 25, no. 19, pp. 4185-4190, 2015.
, “[DBUH][OAc]-catalyzed domino synthesis of novel benzimidazole incorporated 3,5-Bis (Arylidene)-4-piperidones as potential antitubercular agents”, Polycyclic Aromatic Compounds, vol. 42, no. 10, pp. 7010-7024, 2022.
, “Conventional and microwave-assisted organic synthesis of novel antimycobacterial agents bearing furan and pyridine hybrids”, Drug Development Research, vol. 83, no. 2, pp. 416-431, 2022.
, “Biophysical characterization and molecular docking studies of imidazolium based polyelectrolytes-DNA complexes: role of hydrophobicity”, Biomacromolecules, vol. 16, no. 3, pp. 894-903, 2015.